You are here: Home » 2024 » Archives for June 2024

amana Appoints Jack Saidy as Director of Operations in Lebanon

BEIRUT, June 24, 2024 (GLOBE NEWSWIRE) — amana, a leading MENA neobroker, has appointed Jack Saidy as Director of Operations to spearhead its operations in Lebanon, marking a significant milestone in the company's expansion strategy.

Jack Saidy has a strong track record of leadership in financial markets. Previous to joining amana, he held a Director role at Advanced Markets focused on training sales teams and engaging with customers, building his understanding of how to best serve customers in Lebanon and the MENA region. His career in the financial markets spans over 12 years, including a management role at Tickmill, and a previous VP role at amana. His return to amana has been celebrated by the team and allowed for seamless integration into the work culture.

Jack Saidy: “amana offers a premium product with top–notch customer service, support, and ethical trading, filling a market gap in Lebanon. amana allows customers to trade all markets on their platform of choice (app, web, META), while providing 24/6 customer support from our office in downtown Beirut. Regulated by multiple entities including CMA, amana takes additional measures beyond regulatory requirements to promote fair and ethical trading. From highlighting leveraged assets to providing world–class education for free within the app, amana promotes healthy trading and investing practices for the long–term benefit of its customers. This makes me proud to help bring amana to our customers in Lebanon, and fill this market gap.”

amana offers over 5,500 assets on its platforms, allowing customers to trade both physical and leveraged US and MENA shares, commodities, currencies, and more. On amana you can also trade fractional shares of US and MENA stocks.

CEO Muhammad Rasoul: “Hiring Jack and expanding our Lebanon office is a sign of our investment in Lebanon, and our commitment to ensuring our Lebanon customers are getting the level of service they deserve.”

About amana

amana is a leading neobroker in the Middle East. It provides active traders and investors across MENA with direct access to the global and regional financial markets. It operates multiple offices, such as in Beirut, Dubai, and Limassol.

amana is regulated by DFSA in the UAE, the FCA in the UK, CYSEC in Europe, the CMA in Lebanon, the LFSA in Malaysia, and the FSC in Mauritius.

www.amana.app

Contact: Karolina Slowikowska, Director of Communications (karolina.slowikowska@amanacapital.com)

Photo:

https://www.globenewswire.com/NewsRoom/AttachmentNg/90384623–94c2–4f7a–987a–a20bd77ab16d


GLOBENEWSWIRE (Distribution ID 1000967915)

أمانة تعيّن جاك سعيدي مديراً للعمليات في لبنان

بيروت, June 24, 2024 (GLOBE NEWSWIRE) — قامت شركة أمانة، التي تعد من إحدى الشركات الرائدة في مجال الوساطة المالية الإلكترونية في منطقة الشرق الأوسط وشمال أفريقيا، بتعيين جاك سعيدي مديراً للعمليات لقيادة عملياتها التجارية في لبنان، وهي ما تعد خطوة مهمة للغاية فيما يتعلق باستراتيجية الشركة التوسعية.

لدى جاك سعيدي سجل حافل من الخبرة في الأسواق المالية. قبيل انضمامه إلى أمانة، شغل جاك منصب مدير في شركة “أدفانسد ماركت” حيث كان تركيزه على تدريب فريق المبيعات والتواصل مع العملاء، إضافة إلى العمل على كيفية تقديم أفضل خدمة للعملاء في لبنان ومنطقة الشرق الأوسط وشمال أفريقيا. وتمتد مسيرته المهنية في الأسواق المالية لأكثر من 12 عامًا، بما في ذلك دور إداري في شركة Tickmill، إضافة إلى منصب نائب الرئيس السابق في أمانة. وقد احتفل الفريق بعودته إلى أمانة مما أدى إلى سهولة الاندماج في بيئة العمل المحيطة.

وقد صرّح جاك سعيدي: “تسد أمانة فجوة في السوق اللبناني عبر توفير خدمة عملاء ودعم وتداول أخلاقي من الدرجة الأولى. تسمح أمانة للعملاء بالتداول في جميع الأسواق على أي منصة من اختيارهم (التطبيق، الويب، ميتا META)، مع توفير دعم للعملاء على مدار 24 ساعة، ستة أيام في الأسبوع، من مكتبنا في بيروت. وتخضع أمانة لتنظيم العديد من الجهات، بما في ذلك هيئة السوق المالية (CMA)، وتتخذ تدابير إضافية تتجاوز المتطلبات التنظيمية لتعزيز التداول العادل والأخلاقي. بدءًا من تسليط الضوء على الأصول ذات الرافعة المالية وتوفير تعليم عالمي المستوى مجانًا داخل التطبيق، تعمل أمانة على تعزيز ممارسات التداول والاستثمار الصحية لتحقيق المنفعة طويلة المدى لعملائها. وهذا ما يجعلني اشعر بالفخر للمساعدة في دخول أمانة إلى عملائنا في لبنان، وسد هذه الفجوة في السوق”.

تقدم أمانة أكثر من 5500 أصل على منصاتها، مما يسمح للعملاء بالتداول الفعلي والأسهم ذات الرافعة المالية في الولايات المتحدة ومنطقة الشرق الأوسط وشمال إفريقيا والسلع والعملات والمزيد. في أمانة، يمكنك أيضًا تداول أسهم كسرية من الأسهم الأمريكية ومنطقة الشرق الأوسط وشمال أفريقيا.

وتعليقا على الحدث، قال محمد رسول، الرئيس التنفيذي لشركة أمانة: “إن تعيين جاك وتوسيع مكتبنا في لبنان هو علامة على استثمارنا في لبنان، والتزامنا بضمان حصول عملائنا في لبنان على مستوى الخدمة التي يستحقون”.

عن أمانة

أمانة هي شركة وساطة إلكترونية رائدة في الشرق الأوسط. والتي توفر للمتداولين والمستثمرين في جميع أنحاء منطقة الشرق الأوسط وشمال أفريقيا إمكانية الوصول المباشر إلى الأسواق المالية العالمية والإقليمية. ولدى الشركة مكاتب متعددة، في بيروت ودبي وليماسول.

تخضع شركة أمانة للرقابة من قبل سلطة دبي للخدمات المالية (DFSA) في الإمارات العربية المتحدة، وهيئة السلوك المالي (FCA) في المملكة المتحدة، وهيئة الأوراق المالية والبورصة القبرصية (CYSEC) في أوروبا، وهيئة السوق المالية (CMA) في لبنان، وهيئة الأوراق المالية والبورصة القبرصية (CYSEC) في أوروبا، وهيئة لابوان للأوراق المالية (LFSA) في ماليزيا، وهيئة الخدمات المالية (FSC) في موريشيوس.

www.amana.app

للتواصل: كارولينا سلويكوسكا، مديرة الاتصالات 

(karolina.slowikowska@amanacapital.com)

الصورة المصاحبة لهذا الإعلان متاحة على

https://www.globenewswire.com/NewsRoom/AttachmentNg/90384623–94c2–4f7a–987a–a20bd77ab16d 


GLOBENEWSWIRE (Distribution ID 1000967915)

OPEN Health and fusion announce partnership to deliver AI-powered healthcare communications

London, June 24, 2024 (GLOBE NEWSWIRE) — June 24, 2024, London, UK – OPEN Health, a pre–eminent global provider of scientific communications, HEOR and market access, patient engagement, and consulting, today announced a partnership with fusion, an innovative artificial intelligence (AI) and machine learning (ML) solutions provider that will work exclusively with OPEN Health. This alliance will see fusion's market–leading AI capabilities deployed across OPEN Health's extensive global client base, which includes 49 of the top 50 pharmaceutical companies.

Mary McGregor, Founder of fusion, commented, “OPEN Health provides an unrivalled platform to expand the AI agenda globally in our sector. Our longstanding relationship with OPEN Health leadership facilitated early conversations, enabling us to quickly market–test joint solutions, which led to a swift and unanimous decision to formalize this collaboration. This partnership empowers us to redefine the boundaries of what AI can accomplish in healthcare.”

Margot Hannah,  Chief Executive Officer of Scientific Communications at OPEN Health, expressed her enthusiasm for the partnership: “We immediately recognized the need to expand our capabilities and started a dialog with fusion about an exclusive partnership to provide pioneering solutions that integrate OPEN Health’s capabilities with fusion’s cutting–edge expertise in AI and ML. Fusion’s expertise in this area is unparalleled, and we are excited about the possibilities this partnership brings for our clients.”

Steve Duryee, Chief Operating and Transformation Officer at OPEN Health, added, “We are committed to harnessing the power of cutting–edge technologies, including AI, ML, robotic process automation, and data analytics, to drive higher value and improved outcomes for our clients. With the recent launch of our Solutions Innovation Center, and the addition of fusion to our extended team of elite–level technology partners, we are now in the pole position to deliver the most innovative, technologically advanced solutions to our biopharmaceutical partners.”

By integrating with fusion’s advanced technology, OPEN Health underscores its commitment to leading the AI agenda with socially beneficial innovations to drive innovation and efficiency for clients. Contact OPEN Health to set up an interactive demonstration at www.openhealthgroup.com/contact–us.

About OPEN Health
OPEN Health unites world–class scientific, strategic, and creative expertise to solve complex challenges for global biopharma. We are a flexible, global organization, creating high–performing strategic partnerships with our clients. We embrace our different perspectives and strengths to deliver innovative solutions that have a positive impact on commercial and patient outcomes. OPEN Health unlocks possibilities across consulting, HEOR and market access, scientific communications, and patient engagement. To learn more, visit www.openhealthgroup.com.

About fusion
fusion specializes in delivering AI and ML solutions. Known for its advanced technology and innovative approach, fusion aims to transform the pharmaceutical industry by integrating AI–first solutions. To learn more, visit www.fusionagency.solutions.

Attachment


GLOBENEWSWIRE (Distribution ID 9157597)

Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic EXBLIFEP® in Gulf Cooperation Council countries and South Africa

Saint–Louis, France and Weil am Rhein, Germany and Zurich, Switzerland, June 24, 2024 (GLOBE NEWSWIRE) — Allecra Therapeutics (“Allecra”) and Acino today announced the signing of an exclusive licensing agreement under which Acino gains the rights to commercialise Allecra’s antibiotic drug EXBLIFEP® (cefepime/enmetazobactam) within the Republic of South Africa and the member states of the GCC alliance, which includes Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates, effective from 12 June 2024. In addition, the companies have signed a supply agreement under which Allecra will supply the cefepime/enmetazobactam finished product in the above territories.

“Acino has established itself as a leader in South Africa and the GCC region. They are an ideal partner to support us as we build towards commercialisation of EXBLIFEP® following our regulatory approvals in the US and EU,” stated Andreas Kranzusch, Chief Financial Officer and Managing Director at Allecra Therapeutics. “This agreement reflects the understanding that there remains a significant global need to address the dangerous increase of resistance to standard–of–care antibiotics, and we look forward to working with Acino to address this.”

“At Acino, we are dedicated to providing novel healthcare solutions to physicians and patients, aiming to alleviate the health burden in emerging markets. We are incredibly excited to partner with Allecra to offer access to this innovative product in two key geographic regions and, potentially, beyond,” said Andrew Bird, CEO (ai) at Acino. “We are committed to expediting the registration process in these designated markets to ensure hospitals’ swift access to EXBLIFEP® as they continue to fight against high–risk infectious diseases in patients.”

About EXBLIFEP® (cefepime/enmetazobactam)

EXBLIFEP® is an intravenous antibiotic fixed–dose combination of enmetazobactam, a novel extended–spectrum β–lactamase inhibitor belonging to the penicillanic acid sulfone class, with the fourth–generation cephalosporin cefepime. Enmetazobactam has been shown to restore the efficacy of cefepime against some multi–drug resistant bacteria, including ESBL–producing pathogens alone or in combination with some resistant β–lactamase mutations as OXA–48 or AmpC, which are increasing in Europe and for which there are few therapeutic alternatives.

EXBLIFEP® demonstrated statistically significant superior overall treatment success in Allecra’s pivotal Phase III ALLIUM trial, which compared 1034 randomized patients receiving either cefepime 2 g/enmetazobactam 0.5 g or piperacillin 4 g/tazobactam 0.5 g every 8 h as 2 h continuous intravenous infusion in a multi–centre, randomized, controlled, double–blind, global study in 112 sites within nineteen countries.

In February 2024, the U.S. Food and Drug Administration (FDA) approved EXBLIFEP® as a treatment for complicated urinary tract infections (cUTI), including pyelonephritis, in patients 18 years and older. In March 2024 the European Commission (EC) granted marketing authorisation for EXBLIFEP® for the treatment of adult patients with cUTI, including pyelonephritis; hospital–acquired pneumonia (HAP), including ventilator–associated pneumonia (VAP); and bacteraemia that occurs in association with, or is suspected to be associated with any of the infections listed previously.

About Allecra Therapeutics

Allecra Therapeutics, founded in 2013, is a private, clinical–stage biopharmaceutical company developing novel therapies to combat antibiotic resistance by overcoming emergent resistance mechanisms. Lead product candidate EXBLIFEP® (cefepime/enmetazobactam), has successfully completed a randomized, controlled, double–blind, global Phase 3 trial compared to standard of care in patients with complicated urinary tract infections (cUTIs). Based on these results, the company has received FDA marketing approval in the U.S. and announced approval in the European Union for EXBLIFEP® earlier this year.

Allecra has significant patent protection covering proprietary enmetazobactam in major territories. Allecra’s investors include Forbion, Andera Partners, Delos Capital, Xeraya Capital, EMBL Ventures, and BioMedPartners. Allecra’s wholly owned French subsidiary is a beneficiary of financial support from Bpifrance and the Région Alsace. Please visit www.allecra.com for further information.

About Acino

Acino is a Swiss pharmaceutical company headquartered in Zurich with a clear focus on selected markets in the Middle East, Africa, Ukraine, the CIS Region, and Latin America. We deliver quality pharmaceuticals to promote affordable healthcare in these emerging markets and leverage our high–quality pharmaceutical manufacturing capabilities and network to supply leading companies through contract manufacturing and out–licensing. For more information, please visit www.acino.swiss.

Acino is part of Arcera, a global company in the life sciences sector headquartered in Abu Dhabi, United Arab Emirates. Arcera was established by ADQ, an Abu Dhabi–based investment and holding company, to build a global life sciences powerhouse poised to make significant contributions to realising the UAE’s aspiration to emerge as a frontrunner in science and technology. To learn more about Arcera, please visit www.arceralifesciences.com.

Attachments


GLOBENEWSWIRE (Distribution ID 9157528)

Notice of Proposed Settlement and Plan of Allocation Involving Purchasers of Perrigo Common Stock from April 21, 2015 through May 2, 2017 and Owners of Perrigo Common Stock as of November 12, 2015

SEATTLE, June 24, 2024 (GLOBE NEWSWIRE) —

UNITED STATES DISTRICT COURT
DISTRICT OF NEW JERSEY

ROOFER’S PENSION FUND, on behalf of
itself and all others similarly situated,

                        Plaintiff,

        v.

JOSEPH C. PAPA, et al.,

                        Defendants

Case No. 1:16–cv–02805–RMB–LDW

CLASS ACTION


SUMMARY NOTICE OF (I) PROPOSED SETTLEMENT
AND PLAN OF ALLOCATION; (II) SETTLEMENT HEARING; AND
(III) MOTION FOR ATTORNEYS’ FEES AND LITIGATION EXPENSES

To: (1) All persons who purchased Perrigo Company plc’s (“Perrigo”) publicly traded common stock between April 21, 2015 and May 2, 2017, both dates inclusive (the “Class Period”), on the New York Stock Exchange or any other trading center within the United States and were damaged thereby;

(2) All persons who purchased Perrigo’s publicly traded common stock between April 21, 2015 and May 2, 2017, both dates inclusive, on the Tel Aviv Stock Exchange and were damaged thereby; and

(3) All persons who owned Perrigo common stock as of November 12, 2015 and held such stock through at least 8:00 a.m. on November 13, 2015 (whether or not a person tendered their shares in response to the tender offer of Mylan, N.V”).¹


PLEASE READ THIS NOTICE CAREFULLY; YOUR RIGHTS WILL BE AFFECTED BY THE SETTLEMENT OF A CLASS ACTION LAWSUIT PENDING IN THIS COURT.

YOU ARE HEREBY NOTIFIED, pursuant to Rule 23 of the Federal Rules of Civil Procedure and an Order of the United States District Court for the District of New Jersey, that the Court–appointed Lead Plaintiff, on behalf of itself and the Court–certified Class, in the above–captioned securities class action (the “Action”) has reached a proposed settlement of the Action with defendants Perrigo Company plc (“Perrigo”) and Joseph C. Papa (collectively, “Defendants”) for $97,000,000 in cash that, if approved, will resolve all claims in the Action.

A hearing will be held on September 5, 2024 at 10:00 a.m., before the Honorable Leda Dunn Wettre, United States Magistrate Judge, in person in Courtroom 3C of the Martin Luther King Building & U.S. Courthouse, 50 Walnut Street, Newark, NJ 07101, to determine: (i) whether the proposed Settlement should be approved as fair, reasonable, and adequate; (ii) whether the Action should be dismissed with prejudice against Defendants, and the releases specified and described in the Stipulation and Agreement of Settlement dated April 4, 2024 should be granted; (iii) whether the proposed Plan of Allocation should be approved as fair and reasonable; and (iv) whether Lead Counsel’s application for an award of attorneys’ fees and payment of expenses should be approved.

If you are a member of the Class, your rights will be affected by the pending Action and the Settlement, and you may be entitled to share in the Net Settlement Fund. If you have not yet received the full printed Notice of (I) Proposed Settlement and Plan of Allocation; (II) Settlement Hearing; and (III) Motion for Attorneys’ Fees and Litigation Expenses (the “Settlement Notice”) and the Claim Form, you may obtain copies of these documents by contacting the Claims Administrator at Perrigo Securities Litigation, c/o JND Legal Administration, P.O. Box 91374, Seattle, WA 98111, 1–833–674–0175, info@PerrigoSecuritiesLitigation.com. Copies of the Settlement Notice and Claim Form can also be downloaded from the website for the Action, www.PerrigoSecuritiesLitigation.com.

If you are a Class Member, in order to be eligible to receive a payment under the proposed Settlement, you must submit a Claim Form online or postmarked no later than August 26, 2024. If you are a Class Member and do not submit a proper Claim Form, you will not be eligible to share in the distribution of the net proceeds of the Settlement but you will nevertheless be bound by any judgments or orders entered by the Court in the Action.

Any objections to the proposed Settlement, the proposed Plan of Allocation, and/or Lead Counsel’s application for attorneys’ fees and payment of expenses, must be filed with the Court and delivered to Lead Counsel and counsel for Defendants such that they are received no later than August 6, 2024, in accordance with the instructions set forth in the Settlement Notice.

Please do not contact the Court, the Clerk’s office, Perrigo, any other Defendant in the Action, or their counsel regarding this notice. All questions about this notice, the proposed Settlement, or your eligibility to participate in the Settlement should be directed the Claims Administrator or Lead Counsel.

Requests for the Settlement Notice and Claim Form should be made to:

Perrigo Securities Litigation
c/o JND Legal Administration
P.O. Box 91374
Seattle, WA 98111
1–833–674–0175
info@PerrigoSecuritiesLitigation.com
www.PerrigoSecuritiesLitigation.com

Inquiries, other than requests for the Settlement Notice and Claim Form, may be made to Lead Counsel:

Pomerantz LLP
Joshua Silverman
10 S. LaSalle Street
Chicago, IL 60603
1–312–377–1181
jbsilverman@pomlaw.com

Bernstein Litowitz Berger & Grossmann LLP
James A. Harrod
1251 Avenue of the Americas
New York, NY 10020
1–800–380–8496
settlements@blbglaw.com

By Order of the Court

________________________________
¹ Certain persons and entities are excluded from the Class by definition and others are excluded pursuant to request. The full definition of the Class including a complete description of who is excluded from the Class is set forth in the full Settlement Notice referred to above.


GLOBENEWSWIRE (Distribution ID 9154224)

شركة Hisense تكشف النقاب عن أحدث سلسلة من مكبرات الصوت الأفقية لتوفير تجربة السينما المنزلية المتميزة

جوهانسبرغ، جنوب إفريقيا, June 24, 2024 (GLOBE NEWSWIRE) — يسرّ شركة Hisense، وهي الشركة الرائدة في مجال تكنولوجيا الترفيه المنزلي، أن تعلن عن طرح سلسلتها الأحدث من مكبرات الصوت الأفقية، المصمّمة لتحويل تجربة السينما المنزلية بشكل جذري. من شأن مكبرات الصوت الجديدة هذه أن توفر انغماساً صوتياً استثنائياً في المشاهد، وأن ترتقي بأفلامكم ومسلسلاتكم وبرامجكم الرياضية وألعابكم الالكترونية إلى مستويات جديدة من الجودة.

نقدم لكم سلسلة مكبرات الصوت HS3100 من Hisense

يأتي مكبر الصوت الأفقي HS3100 من Hisense مع مضخم صوت قوي مقاس 6.5 بوصة، ويتميز بأحدث تقنيات الصوت المحيطي الافتراضي DTS Virtual وDolby Digital Plus. يسمح هذا المزيج من التقنيات المتطورة بضمان تجربة صوتية منقطعة النظير، إذ يوفر صوتاً غنياً وواضحاً عبر جميع الترددات ويمنحكم صوتاً فائقاً ومذهلاً بقوة 480 واط. هذا ويشكّل مضخّم الصوت اللاسلكي ملحقاً أساسياً لمكبر الصوت الأفقي، ويقدم صوتاً جهيراً عميقاً وحيوياً، يسمح بتعزيز وضوح الحوار ومشاهد الحماس والإثارة.

تعرّفوا على سلسلة HS5100 من Hisense

تستكمل سلسلة مكبرات الصوت الأفقية HS5100 من Hisense نجاح سلسلة HS3100، وتوفر الإعدادات عالية الجودة الخاصة بمكبرات ومضخمات الصوت، إلا أنها توفر صوتاً فائقاً ومذهلاً أكثر قوة، تصل إلى 540 واط. يساهم هذا النظام الصوتي بنقل المشاهد إلى قلب الحدث، ويخلق تجربة مشاهدة غامرة بالفعل.

تدعم السلسلتان من مكبرات الصوت الجديدة تقنية بلوتوث 5.3 ويتميزان بخيار الانتقال إلى وضع التلفزيون الذي يقترن بسلاسة مع مختلف أجهزة تلفزيون Hisense. تتيح وظيفة EzPlay المبتكرة تبسيط عملية التحكم بنظام الصوت، من خلال إنشاء قائمة إعدادات يمكن فتحها عند الطلب على تلفزيون Hisense الخاص بكم. تتيح هذه الخاصية ضبط مكبر الصوت الأفقي باستخدام جهاز التحكم عن بعد المخصص للتلفزيون، ما يعزز الراحة وتجربة المستخدم.

ارتقوا بتجربتكم الصوتية إلى مستويات جديدة

تمّ تصميم مكبرات الصوت الأفقية من Hisense لتوفير تجربة صوتية فائقة، بصرف النظر عن العلامة التجارية للتلفزيون الذي تمتلكونه. تجدر الإشارة إلى أن مكبرات الصوت هذه متاحة في متاجر البيع بالتجزئة الرائدة في جميع أنحاء جنوب إفريقيا، ومجهزة بميزات متقدمة لتلبية جميع احتياجاتكم الصوتية، ما يضمن لكم الحصول على أفضل تجارب الترفيه المنزلي والتمتع بها.

اختبروا مستقبل السينما المنزلية بفضل أحدث سلسلة من مكبرات الصوت الأفقية من Hisense، التي تضع معياراً جديداً لجودة الصوت والابتكار.

لمشاهدة الصورة المرفقة بهذا البيان الصحفي، يُرجى زيارة الرابط الإلكتروني التالي:

https://www.globenewswire.com/NewsRoom/AttachmentNg/79920907–7738–4e55–9e34–2d0701b1735d

جهة الاتصال:

Henru van der Merwe
henru.vandermerwe@hisense.com


GLOBENEWSWIRE (Distribution ID 1000967848)

Hisense dévoile des barres de son de pointe pour une expérience cinématographique ultime à domicile

JOHANNESBOURG, Afrique du Sud, 24 juin 2024 (GLOBE NEWSWIRE) — Hisense, leader de la technologie de divertissement à domicile, est ravie d'annoncer le lancement de ses dernières barres de son conçues pour révolutionner votre expérience cinématographique à domicile. Ces nouvelles barres de son promettent une expérience audio immersive exceptionnelle, élevant vos films, séries, sports et jeux vidéo préférés vers de nouveaux sommets.

Présentation de la Hisense HS3100

La barre de son Hisense HS3100, associée à un caisson de basses robuste de 6,5 pouces, intègre les technologies de pointe DTS Virtual et Dolby Digital Plus. Cette combinaison garantit une expérience audio inégalée, offrant un son riche et clair sur toutes les fréquences avec une puissance audio impressionnante de 480 W. Le caisson de basses sans fil complète la barre de son en fournissant des basses profondes et puissantes, améliorant à la fois la clarté des dialogues et l'impact des scènes d'action.

Découvrez la Hisense HS5100

Par suite du succès réalisé par HS3100, la Hisense HS5100 propose la même configuration barre de son et caisson de basses de haute qualité, mais avec une puissance audio plus élevée de 540W. Ce système vous place au cœur de l'action, créant ainsi une expérience de vision véritablement immersive.

Les deux modèles prennent en charge Bluetooth 5.3 et disposent d'un mode TV qui se couple parfaitement avec les téléviseurs Hisense. La fonction innovante EzPlay simplifie le contrôle de votre système audio, en offrant un menu contextuel de paramètres sur votre téléviseur Hisense. Cela vous permet de régler votre barre de son à l'aide de la télécommande de votre téléviseur, améliorant ainsi la commodité et l'expérience utilisateur.

Améliorez votre expérience audio

Les barres de son Hisense sont conçues pour offrir une expérience audio supérieure, quelle que soit la marque de votre téléviseur. Disponibles chez les principaux détaillants d'Afrique du Sud, ces barres de son sont dotées de fonctionnalités avancées pour répondre à tous vos besoins en matière de son, vous garantissant ainsi le meilleur du divertissement à domicile.

Découvrez l'avenir du cinéma à domicile avec les plus récentes barres de son Hisense, qui visent à établir une nouvelle norme en matière de qualité audio et d'innovation.

Contact :
Henru van der Merwe
henru.vandermerwe@hisense.com

Une photo accompagnant cette annonce est disponible sur le lien suivant : https://www.globenewswire.com/NewsRoom/AttachmentNg/79920907–7738–4e55–9e34–2d0701b1735d


GLOBENEWSWIRE (Distribution ID 1000967848)

Hisense TV Global No.2, Hisense Never Settle For No.2 Globally

JOHANNESBURG, June 23, 2024 (GLOBE NEWSWIRE) — Hisense, a brand synonymous with innovation and quality, has carved a significant niche in the global TV market. Embracing the philosophy “Hisense Never Settle For No.2 Globally,” the company showcases its determination to lead the industry. With an impressive journey marked by significant achievements, Hisense continuously strives to be the world's number one.

Global Recognition and Market Leadership

Hisense's dedication to excellence is reflected in its remarkable global standings. In the competitive landscape of TV manufacturing, Hisense has risen to the forefront, earning the second position in global TV shipments. This achievement underscores the brand's growth and its commitment to providing superior products to consumers worldwide.

Notably, Hisense has also claimed the top spot in the 100–inch TV segment. This milestone highlights the brand's dominance in the large–screen market, delivering unparalleled viewing experiences. Furthermore, Hisense's innovative Laser TV technology has secured the number one position globally, showcasing the company's prowess in pioneering new entertainment solutions.

Market Dominance

Hisense's impact extends beyond global rankings to regional leadership. The brand has become a household name in numerous countries, with notable market shares in South Africa, Japan, Canada, Mexico, and Australia. This widespread recognition reflects the trust and loyalty that consumers place in Hisense products, which are known for their cutting–edge technology and exceptional quality.

Sponsoring Excellence: EURO 2024

Building on its commitment to excellence, Hisense proudly sponsors the UEFA EURO 2024 football tournament. This prestigious sponsorship underscores Hisense's dedication to sports and innovation, reflecting the brand's ambition to connect with global audiences and enhance the viewing experience. As fans around the world gear up for this exciting event, Hisense aims to bring the thrill of the game into homes with its state–of–the–art TVs.

Hisense's journey is a testament to its relentless pursuit of excellence. By never settling for second best, Hisense continues to innovate and lead in the global market, setting new standards and inspiring consumers worldwide. As Hisense gears up for EURO 2024, the brand's commitment to quality and performance remains unwavering, promising an extraordinary experience for all.


GLOBENEWSWIRE (Distribution ID 1000967841)

BYD Introduz Novo Portfólio de Energia no The smarter E Europe e Comemora 1 Milhão de Sistemas Batterybox Instalados

SHENZHEN, China e MUNIQUE, June 22, 2024 (GLOBE NEWSWIRE) — A BYD Co. Ltd. (HKSE: 1211), um dos maiores fabricantes de baterias recarregáveis e veículos elétricos do mundo, introduziu suas soluções de energia renovável no “The Smarter E Europe” entre 19 e 21 de junho. A exposição no estande B1.130, B1.131 apresentou os mais recentes sistemas de armazenamento de energia BatteryBox, BatteryMax Lite e BYD MC Cube–T para aplicações em escala de serviços públicos, comerciais e industriais. Os visitantes puderam explorar o veículo elétrico “Seal” da BYD e conhecer o papel da BYD como Parceiro Oficial de Mobilidade Eletrônica do UEFA Euro 2024™.

Desde o seu lançamento em 2015, a série BYD BatteryBox tornou–se uma solução líder de armazenamento de energia residencial em todo o mundo, com mais de 1 milhão de instalações e um histórico de segurança impecável. No dia 19 de junho, às 15h, a BYD realizou um evento especial para agradecer aos seus parceiros. Yin Xiaoqiang, Gerente Geral da BYD Energy Storage, entregou os certificados e prêmios, como ingressos para a final do UEFA Euro 2024 e sistemas BatteryBox, aos distribuidores e instaladores. O portfólio completo do BYD BatteryBox Premium, incluindo os modelos de alta tensão HVs/HVM e os modelos de baixa tensão LVL/LVs, estavam em exibição. Uma nova unidade de controle de bateria (BCU) para as séries HVM e HVs também foi introduzida, simplificando a instalação, eliminando a necessidade de remover as tampas para conexões dos cabos.

Lançado na ees Europe 2024, o novo BatteryMax Lite foi projetado para aplicações comerciais e industriais, oferecendo soluções escaláveis de 30kWh a 90kWh e até 5,76MWh com conexões paralelas. Compatível com inversores de marcas como SMA e Goodwe, o BatteryMax Lite estará disponível para pré–encomenda a partir de agosto, com entregas a partir do quarto trimestre. A previsão da disponibilidade do sistema na Europa é para outubro de 2024.

Na ees Europe 2024, a BYD recebeu o prêmio de “Top Brand PV Storage Europe 2024” (Principal Marca de Armazenamento de PV da Europa de 2024) e o de “Top Brand PV Storage 2024” (Principal Marca de Armazenamento de PV de 2024) em vários países europeus, incluindo Bélgica, Alemanha, Itália, Polônia, Espanha, Áustria e Reino Unido. O prêmio deste ano classificou novamente a BYD como a marca líder em sistemas de armazenamento de energia PV com base nas avaliações de instaladores e distribuidores de toda a Europa.

Jiang Feng, Diretor de Armazenamento de Energia Residencial da BYD, destacou a importância dos mercados europeus e o objetivo da empresa de fornecer soluções de energia verde. A parceria da BYD com a UEFA Euro 2024™ se alinha com a promoção de soluções ecológicas de energia e mobilidade.

Para mais informação, visite:

www.byd.com

www.bydenergy.com

www.batterybox.com

Informações de Contato: essmarketing@fdbatt.com

Foto deste comunicado disponível em https://www.globenewswire.com/NewsRoom/AttachmentNg/66a5ccab–1c68–42cb–bbeb–b8fc0862b882

Vídeo deste comunicado disponível em https://www.globenewswire.com/NewsRoom/AttachmentNg/ada7c6ac–1527–420a–ad1e–c8bf290074c0


GLOBENEWSWIRE (Distribution ID 9157759)

Standards Alliance Awards Inteleos Foundation to Expand Ultrasound Training in Kenya

ROCKVILLE, Md., June 21, 2024 (GLOBE NEWSWIRE) — The Inteleos Foundation, a public non–profit organization driving positive health outcomes through education in medical imaging, received a three–year, $180,000 subaward from the Standards Alliance Phase 2 (SA2) Program; a public private partnership between United States Agency for International Development (USAID) and the American National Standards Institute (ANSI), to fund an innovative ultrasound training program in Kenya.

The SA2 program implemented by ANSI aims to help increase the capacity of developing countries to implement accepted international best practices around National Quality Infrastructure (NQI) and prevent or remove non–tariff barriers, and stimulate economic growth, while also preserving and expanding markets for U.S. businesses.

In collaboration with Inteleos, a non–profit certification organization, the activity will support the Inteleos Foundation’s efforts to establish standardized ultrasound education and certification at a national scale to increase access to essential ultrasound services across Kenya. This initiative aligns with SA2's focus on improving maternal health outcomes through expanding access to point–of–care ultrasound, including developing training curriculum and certification for midwives and nurses.

“We are grateful for the generous support of ANSI and USAID. The subaward will allow us to make significant strides in building the ultrasound workforce capacity in Kenya,” said Pamela Ruiz, chief business development officer at Inteleos. “This funding enables us, with local partners, to develop a standard level of proficiency and certification for primary maternal clinicians for high–quality ultrasound care, ultimately improving maternal and fetal health outcomes.”

The Standards Alliance funding will be distributed over three years to fund the following key initiatives:

  • Establish a national task force to recommend policies for ultrasound practice by nurses, midwives and maternal clinicians
  • Develop a standardized ultrasound curriculum in partnership with educational institutions
  • Implement ultrasound training and certification programs, targeting 90 trainees in the first year
  • Expand ultrasound training to reach more healthcare providers across multiple regions
  • Evaluate the impact of training on clinicians and patients
  • Develop a sustainable financing model to ensure program continuity

“Developing an activity to work in the health sector in Kenya was a natural fit under the Standards Alliance’s goals, and we are pleased to be working with Inteleos, as their expertise in the field will help improve maternal health in Kenya and foster development,” said Leslie McDermott, senior director for the International Development department at ANSI.

“The collaboration between USAID–ANSI’s Standards Alliance and Inteleos in Kenya is playing a vital role in helping our partner country achieve its development goals,” said Daniel Vazquez, USAID's senior standards specialist. “This work under the Standards Alliance exemplifies our Agency's ability to work in innovative ways with the U.S. private sector to achieve sustainable development results. Leveraging its expertise and localizing it within Kenyan partners is critical to our approach.”

Inteleos will work closely with the Kenyan Ministry of Health, healthcare facilities, academic institutions like Amref International University and professional associations to execute this comprehensive program, as well as the USAID local Mission in the country. The project aims to address the critical need for accessible and skilled ultrasound services, particularly in regions with high maternal mortality rates.

“For the five years Amref International University has actively trained on Point of Care Obstetric Ultrasound screening (OPOCUS), there is evidence that this is the gateway to mitigating risks that are associated with preventable maternal deaths in developing countries,” said Dr. Micah Matiang’i, principal investigator, OPOCUS training at the Amref International University.

The ultrasound training initiative in Kenya aligns with USAID's regional health priorities and commitment to strengthening healthcare systems and improving access to quality care highlighted in their Kenya Country Development Cooperation Strategy.

Learn more about the Inteleos Foundation and its global health initiatives.
Learn more about the Standards Alliance Phase 2 program.

About Inteleos
Inteleos™ is a non–profit organization that fuels the global health community to ensure access to quality care. Inteleos is the overarching governance and management organization for the American Registry for Diagnostic Medical Sonography® (ARDMS®) the Alliance for Physician Certification & Advancement™ (APCA™) and the Point–of–Care Ultrasound Certification Academy™ (PCA) which together represents more than 141,000 certified medical professionals throughout the world.

About the Inteleos Foundation
The Inteleos Foundation accelerates the global expansion of the mission–driven work of Inteleos, ARDMS, APCA and the POCUS Certification Academy through its philanthropic efforts.


GLOBENEWSWIRE (Distribution ID 9157628)